Acadia Healthcare (NASDAQ:ACHC) was upgraded by research analysts at Cantor Fitzgerald from a “neutral” rating to an “overweight” rating in a research report issued on Sunday. Cantor Fitzgerald also issued estimates for Acadia Healthcare’s FY2018 earnings at $2.51 EPS.
A number of other research analysts also recently commented on ACHC. Mizuho downgraded Acadia Healthcare from a “buy” rating to a “neutral” rating and set a $36.00 target price for the company. in a research report on Sunday, October 29th. Credit Suisse Group initiated coverage on Acadia Healthcare in a research report on Thursday, November 2nd. They set a “neutral” rating and a $35.00 target price for the company. Robert W. Baird reiterated a “hold” rating and set a $37.00 target price on shares of Acadia Healthcare in a research report on Friday, December 15th. Jefferies Group set a $42.00 target price on Acadia Healthcare and gave the company a “buy” rating in a research report on Tuesday, December 19th. Finally, BidaskClub upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, December 27th. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $44.46.
Shares of Acadia Healthcare (ACHC) opened at $38.57 on Friday. The company has a current ratio of 1.25, a quick ratio of 1.36 and a debt-to-equity ratio of 1.25. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $54.34. The stock has a market cap of $3,386.76, a P/E ratio of 16.84, a price-to-earnings-growth ratio of 1.24 and a beta of 0.85.
In related news, Director Reeve B. Waud sold 100,000 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $31.80, for a total value of $3,180,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently modified their holdings of the stock. State of Alaska Department of Revenue bought a new stake in Acadia Healthcare in the fourth quarter worth $150,000. Tyers Asset Management LLC lifted its position in Acadia Healthcare by 31.8% in the fourth quarter. Tyers Asset Management LLC now owns 5,904 shares of the company’s stock worth $193,000 after buying an additional 1,424 shares during the last quarter. Xact Kapitalforvaltning AB bought a new stake in Acadia Healthcare in the fourth quarter worth $231,000. CIBC World Markets Inc. bought a new stake in Acadia Healthcare in the fourth quarter worth $236,000. Finally, Arthur Zaske & Associates LLC bought a new stake in Acadia Healthcare in the third quarter worth $283,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.